Daratumumab, carfilzomib, and dexamethasone in relapsed or refractory myeloma: final analysis of PLEIADES and EQUULEUS.

Autor: Moreau P; Hematology, University Hospital Hôtel-Dieu, Nantes, France. philippe.moreau@chu-nantes.fr., Chari A; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Oriol A; Institut Català d'Oncologia and Institut Josep Carreras, Hospital Germans Trias i Pujol, Barcelona, Spain., Martinez-Lopez J; Hospital 12 de Octubre, H12O-CNIO, Haematological Malignancies Clinical Research Unit, Universidad Complutense, CIBERONC, Madrid, Spain., Haenel M; Klinikum Chemnitz, Chemnitz, Germany., Touzeau C; Hematology, University Hospital Hôtel-Dieu, Nantes, France., Ailawadhi S; Mayo Clinic Florida, Jacksonville, FL, USA., Besemer B; Universitaetsklinikum Tuebingen der Eberhard-Karls-Universitaet, Abteilung fuer Innere Medizin II, Tübingen, Germany., de la Rubia Comos J; Hospital La Fe, School of Medicine and Dentistry, Catholic University of Valencia, Valencia, Spain.; CIBERONC, Instituto Carlos III, Madrid, Spain., Encinas C; Hospital General Universitario Gregorio Marañón (HGUGM), IiSGM, Madrid, Spain., Mateos MV; University Hospital of Salamanca/IBSAL/Cancer Research Center-IBMCC (USAL-CSIC), Salamanca, Spain., Salwender H; Asklepios Tumorzentrum Hamburg, AK Altona and AK St. Georg, Hamburg, Germany., Rodriguez-Otero P; Clínica Universidad de Navarra, Pamplona, Spain., Hulin C; Department of Hematology, Hôpital Haut Lévêque, University Hospital, Pessac, France., Karlin L; Department of Hematology, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Pierre-Bénite, France., Sureda Balari A; Hematology Department, Institut Català d'Oncologia - Hospitalet, IDIBELL, University of Barcelona, Barcelona, Spain., Bargay J; Hospital Universitari Son Llàtzer, IdISBa, Palma de Mallorca, Illes Balears, Spain., Benboubker L; Service d'Hématologie et Thérapie Cellulaire, Hôpital Bretonneau, Centre Hospitalier Régional Universitaire (CHRU), Tours, France., Rosiñol L; Hospital Clínic de Barcelona, IDIBAPS, Barcelona, Spain., Tarantolo S; Nebraska Cancer Specialists, Omaha, NE, USA., Terebelo H; Providence Cancer Center, Southfield, MI, USA., Yang S; Janssen Research & Development, LLC, Spring House, PA, USA., Wang J; Janssen Research & Development, LLC, Spring House, PA, USA., Nnane I; Janssen Research & Development, LLC, Spring House, PA, USA., Qi M; Janssen Research & Development, LLC, Spring House, PA, USA., Kosh M; Janssen Research & Development, LLC, Spring House, PA, USA., Delioukina M; Janssen Research & Development, LLC, Spring House, PA, USA., Goldschmidt H; GMMG-Study Group at University Hospital Heidelberg, Internal Medicine V, Heidelberg, Germany.
Jazyk: angličtina
Zdroj: Blood cancer journal [Blood Cancer J] 2023 Mar 07; Vol. 13 (1), pp. 33. Date of Electronic Publication: 2023 Mar 07.
DOI: 10.1038/s41408-023-00805-x
Databáze: MEDLINE